With over 40% of Americans classified as obese, the need for effective long-term weight-loss solutions is greater than ever. Obesity can lead to serious health issues like diabetes, heart disease, ...

Strong efficacy and cardiovascular benefits should allow Novo to continue growing sales of GLP-1 therapies in diabetes. Ozempic and Rybelsus helped Novo gain share over Eli Lilly's once-weekly ...

The Trump administration has pledged to curb rising obesity with school meal reforms and artificial dye bans, though the ...

A major new study has shown that a group of drugs called GLP-1 receptor agonists offer strong protection for both the kidneys ...

Ozempic (semaglutide) and other GLP-1 medications have helped many people lose weight and manage chronic conditions like type ...

The appetite-suppressing medications reduce consumption of processed and sugary foods, creating new risks and opportunities.

New research has revealed that people taking weight loss drugs like Wegovy and Mounjaro are increasingly more likely to ...

The overarching commonality is that there isn't one: "Not all people experiences the same degree of facial and body changes ...

The exterior sign at Evernorth Health Services located at One Express Scripts Way as photographed on Monday, Dec. 30, 2024, ...

First, a drug like Ozempic mimics the natural GLP-1 hormone in your gut, which slows down digestion in the stomach and ...

A healthy fasting blood glucose level for a person without diabetes is roughly 70 milligrams per deciliter to 99 milligrams ...

GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...